4661 - 4670 of 7730 Results
Title
Year
- Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy study2019RESTRICTEDTitle: Levels of glutamatergic neurometabolites in patients with severe treatment-resistant schizophrenia: a proton magnetic resonance spectroscopy studyJournal Name: NeuropsychopharmacologyPublisher: Springer Science and Business Media LLCVol: 45Issue #: 4Start Page: 632End Page: 640Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41386-019-0589-zBest OA location URL: https://www.nature.com/articles/s41386-019-0589-z.pdfCitation Count: 51
- Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's Disease2019RESTRICTEDTitle: Participant and Study Partner Reported Impact of Cognition on Functional Activities in Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 1Start Page: 61End Page: 69Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12870Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12870Citation Count: 9
- Differences in topological progression profile among neurodegenerative diseases from imaging data2019RESTRICTEDTitle: Differences in topological progression profile among neurodegenerative diseases from imaging dataJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.49298Best OA location URL: https://doi.org/10.7554/elife.49298Citation Count: 9
- Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic Review2019RESTRICTEDTitle: Measurement Instruments to Assess Functional Mobility in Parkinson's Disease: A Systematic ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 7Issue #: 2Start Page: 129End Page: 139Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12874Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12874Citation Count: 27
-
RESTRICTEDTitle: Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory diseaseJournal Name: NaturePublisher: Springer Science and Business Media LLCVol: 577Issue #: 7788Start Page: 103End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41586-019-1828-5Best OA location URL: https://europepmc.org/articles/pmc6930849?pdf=renderCitation Count: 222
-
RESTRICTEDTitle: PINK1 phosphorylates ubiquitin predominantly in astrocytesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 5Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-019-0101-9Best OA location URL: https://www.nature.com/articles/s41531-019-0101-9.pdfCitation Count: 28
-
RESTRICTEDTitle: Sex Differences in Cognitive Changes in De Novo Parkinson’s DiseaseJournal Name: Journal of the International Neuropsychological SocietyPublisher: Cambridge University Press (CUP)Vol: 26Issue #: 2Start Page: 241End Page: 249Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1017/s1355617719001085Best OA location URL: https://europepmc.org/articles/pmc7282562?pdf=renderCitation Count: 8
- The Role of the Cerebellum in Degenerative Ataxias and Essential Tremor: Insights From Noninvasive Modulation of Cerebellar Activity2019RESTRICTEDTitle: The Role of the Cerebellum in Degenerative Ataxias and Essential Tremor: Insights From Noninvasive Modulation of Cerebellar ActivityJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 2Start Page: 215End Page: 227Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27919Best OA location URL: https://movementdisorders.onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27919Citation Count: 47
- Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial Designs2019RESTRICTEDTitle: Development of a Disease Progression Model for Leucine‐Rich Repeat Kinase 2 in Parkinson's Disease to Inform Clinical Trial DesignsJournal Name: Clinical Pharmacology & TherapeuticsPublisher: WileyVol: 107Issue #: 3Start Page: 553End Page: 562Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/cpt.1634Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939141Citation Count: 13
- LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patients2019RESTRICTEDTitle: LRRK2 kinase activity regulates lysosomal glucocerebrosidase in neurons derived from Parkinson’s disease patientsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-019-13413-wBest OA location URL: https://www.nature.com/articles/s41467-019-13413-w.pdfCitation Count: 132